Picture [LSA] – The Business Web Portal 650x89px
Person › Details

Mark Doak (Agilent Technologies, CrossLab Group (ACG) [Services + Consumables])

Doak, Mark (Agilent 201409– President of newly created CrossLab Group joined HP 1982)


Organisation Organisation Agilent Technologies, CrossLab Group (ACG) [Services + Consumables]
Products Product laboratory equipment services
  Product 2 reagents (bio/biochemical)

Agilent Technologies Inc.. (9/17/14). "Press Release: Agilent Technologies Creates New Group for Services and Consumables. Mark Doak Named President of Agilent CrossLab Group". Santa Clara, CA.

Agilent Technologies Inc. (NYSE: A) today announced it has created a new services and consumables organization, the Agilent CrossLab Group, and named Mark Doak group president, effectively immediately. Doak has been senior vice president and general manager of the Services and Support Division.

"Services has become a strategic business for Agilent under Mark's leadership," said Mike McMullen, Agilent president and chief operating officer.

"Building on industry-leading customer support experience, Mark has led a strategic transformation of our Services business," McMullen said. "He has worked in close partnership with our customers to provide services optimizing their laboratory operations, and in doing so has taken the services business from instrument repair to today's laboratory productivity solutions. The Services business now accounts for over 20 percent of Agilent's revenues."

"Consumables, under the leadership of Helen Stimson, is a natural part of the customer experience," he added. "By unifying our CrossLab Services and Consumables initiatives into this newly created business group, Mark and Helen will form an even more powerful partnership that will further help our customers optimize the economics and science of their laboratory operations."

Doak has been in the analytical and scientific instrument industry for 36 years, starting his career at Beckman Instruments. He joined Hewlett-Packard Co., Agilent's predecessor company, in 1982. At Agilent he has been responsible for the global services business spanning Life Sciences and Applied Markets. Over his career at Agilent he has held various senior management positions across marketing, quality and services. He holds an MBA from Michael J. Coles College of Business at Kennesaw State University in Atlanta, Georgia, and a Bachelor of Science in electrical engineering technology from Ohio Institute of Technology, Columbus, Ohio.

In separate news, Agilent announced today that Agilent President and CEO Bill Sullivan will retire on Oct. 31, 2015. Mike McMullen has been named his successor effective March 18, 2015, with Sullivan serving as an advisor until his retirement. McMullen has been promoted, effective immediately, to president and chief operating officer.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at

In September 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. On Aug. 1, 2014, the company's electronic measurement business began operating as Keysight Technologies, Inc., a wholly owned subsidiary. The separation is expected to be completed in early November 2014.

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding the CEO transition plan; the separation of Agilent's electronic measurement business; future revenues, earnings and profitability; the future demand for the company's products and services; and customer expectations. These forward-looking statements involve risks and uncertainties that could cause Agilent's results to differ materially from management's current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of our customers' businesses; unforeseen changes in the demand for current and new products, technologies, and services; customer purchasing decisions and timing, and the risk that we are not able to realize the savings expected from integration and restructuring activities.

In addition, other risks that Agilent faces include those detailed in Agilent's filings with the Securities and Exchange Commission, including our latest Form 10-K and Form 10-Q. Forward-looking statements are based on the beliefs and assumptions of Agilent's management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

# # #

Editorial Contact:

Michele Drake
+1 408 345-8396

Investor Contact:

Alicia Rodriguez
+1 408 345-8948

Record changed: 2019-06-09


Picture [LSA] – The Business Web Portal 650x89px

More documents for Mark Doak

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group BIO-Europe 2019 Partnering Open BEU2019 650x80px

» top